| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |